Ethical, Legal, Social, and Financial Implications of Human Genome Research in Developing and the Least-Developing Nations

This project investigated the introduction of genomic research into the developing and the least developed nations. Initially, the basic demographic and epidemiological characteristics of these two geographical areas were provided. The enormous economic impact and medical benefits of genomics in the industrialized nations were outlined to exemplify the innovative applications of genomics. Efforts were made to compare the diffusion of genomic scientific interventions into the progressive developing nations such as Brazil, Russia, India, China and Southern Africa (The BRICS) and the least developing nations as Angola, Bangladesh, Benin, Burkina-Faso, Cambodia, Chad, Gambia, Haiti, Rwanda, Senegal and Uganda among others. The ethical implications of introducing innovative genomic research into these two sets of nations were summarized. The researcher also compared the legal implications of introducing human genome sequencing research in the two distinct group of nations and a contrast was provided about the key social implications of the genomic research project. Finally, the financial capital required to implement genomics research interventions in the two characteristic groups of nations was discussed.